LAV Biosciences Fund V, L.P.
SEC insider (Form 3/4/5 filer). CIK 0001764435. 10% Owner at ADARx Pharmaceuticals, Inc. (ADRX). 6 reported Form 4/5 transactions since Sep 2024; latest on Sep 28, 2026. Located in CENTRAL.
Companies LAV Biosciences Fund V, L.P. has filed insider reports for
- ADARx Pharmaceuticals, Inc. (ADRX): 10% Owner
LAV Biosciences Fund V, L.P.
CIK: 0001764435
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)6 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ADRX
ADARx Pharmaceuticals, Inc.
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Sep 28, 2026ADRX
ADARx Pharmaceuticals, Inc.
ConversionDirect8.9M shares- - Sep 28, 2026ADRX
ADARx Pharmaceuticals, Inc.
ConversionDirect1.7M shares- - Sep 28, 2026ADRX
ADARx Pharmaceuticals, Inc.
ConversionDirect513.1K shares- - Sep 28, 2026ADRX
ADARx Pharmaceuticals, Inc.
ConversionDirect153.9K shares- - Sep 28, 2026ADRX
ADARx Pharmaceuticals, Inc.
ConversionIndirect307.7K shares- - Sep 28, 2026ADRX
ADARx Pharmaceuticals, Inc.
ConversionIndirect307.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Conversion | 8,908,775 | - | $0 | Direct |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Conversion | 1,667,469 | - | $0 | Direct |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Conversion | 513,067 | - | $0 | Direct |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Conversion | 153,868 | - | $0 | Direct |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Conversion | 307,738 | - | $0 | Indirect |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Conversion | 307,738 | - | $0 | Indirect |
1-6 of 6 transactions